Inducible Glutamate Oxaloacetate Transaminase as a Therapeutic Target Against Ischemic Stroke

Antioxidants and Redox Signaling - United States
doi 10.1089/ars.2014.6106
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Hypoxia Inducible Factor 1 as a Therapeutic Target in Ischemic Stroke

Current Medicinal Chemistry
Organic ChemistryBiochemistryDrug DiscoveryMolecular MedicinePharmacology
2009English

Human Recombinant Glutamate Oxaloacetate Transaminase 1 (GOT1) Supplemented With Oxaloacetate Induces a Protective Effect After Cerebral Ischemia

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2014English

Heat Shock Protein 27 (HSP27) as a Therapeutic Target in Ischemic Stroke and Neurodegenerative Disorders

Juntendo Medical Journal
2017English

Evaluating Hypoxia-Inducible Factor-1α as a Cancer Therapeutic Target via Inducible RNA InterferenceIn Vivo

Cancer Research
Cancer ResearchOncology
2005English

Nucleophosmin Phosphorylation as a Diagnostic and Therapeutic Target for Ischemic AKI

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2018English

A Novel Therapeutic Peptide as a Partial Agonist of RANKL in Ischemic Stroke

Scientific Reports
Multidisciplinary
2016English

Glutamate-Oxaloacetate Transaminase Activity Promotes Palmitate Lipotoxicity in Rat Hepatocytes by Enhancing Anaplerosis and Citric Acid Cycle Flux

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2018English

Lysosomes as a Therapeutic Target

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2019English

Transglutaminase 2 Protects Against Ischemic Stroke

Neurobiology of Disease
Neurology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy